APA
Hartz R. A., Ahuja V. T., Rafalski M., Schmitz W. D., Brenner A. B., Denhart D. J., Ditta J. L., Deskus J. A., Yue E. W., Arvanitis A. G., Lelas S., Li Y., Molski T. F., Wong H., Grace J. E., Lentz K. A., Li J., Lodge N. J., Zaczek R., Combs A. P., Olson R. E., Mattson R. J., Bronson J. J. & Macor J. E. (20090825). In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. : Journal of medicinal chemistry.
Chicago
Hartz Richard A, Ahuja Vijay T, Rafalski Maria, Schmitz William D, Brenner Allison B, Denhart Derek J, Ditta Jonathan L, Deskus Jeffrey A, Yue Eddy W, Arvanitis Argyrios G, Lelas Snjezana, Li Yu-Wen, Molski Thaddeus F, Wong Harvey, Grace James E, Lentz Kimberley A, Li Jianqing, Lodge Nicholas J, Zaczek Robert, Combs Andrew P, Olson Richard E, Mattson Ronald J, Bronson Joanne J and Macor John E. 20090825. In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. : Journal of medicinal chemistry.
Harvard
Hartz R. A., Ahuja V. T., Rafalski M., Schmitz W. D., Brenner A. B., Denhart D. J., Ditta J. L., Deskus J. A., Yue E. W., Arvanitis A. G., Lelas S., Li Y., Molski T. F., Wong H., Grace J. E., Lentz K. A., Li J., Lodge N. J., Zaczek R., Combs A. P., Olson R. E., Mattson R. J., Bronson J. J. and Macor J. E. (20090825). In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. : Journal of medicinal chemistry.
MLA
Hartz Richard A, Ahuja Vijay T, Rafalski Maria, Schmitz William D, Brenner Allison B, Denhart Derek J, Ditta Jonathan L, Deskus Jeffrey A, Yue Eddy W, Arvanitis Argyrios G, Lelas Snjezana, Li Yu-Wen, Molski Thaddeus F, Wong Harvey, Grace James E, Lentz Kimberley A, Li Jianqing, Lodge Nicholas J, Zaczek Robert, Combs Andrew P, Olson Richard E, Mattson Ronald J, Bronson Joanne J and Macor John E. In vitro intrinsic clearance-based optimization of N3-phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists. : Journal of medicinal chemistry. 20090825.